Literature DB >> 24521480

Ligustilide attenuates inflammatory pain via inhibition of NFκB-mediated chemokines production in spinal astrocytes.

Lin-Xia Zhao1, Bao-Chun Jiang, Xiao-Bo Wu, De-Li Cao, Yong-Jing Gao.   

Abstract

Ligustilide (LIG) is a major component of Radix Angelica Sinensis, and reportedly has neuroprotective and anti-inflammatory effects. Recent studies have demonstrated that spinal astrocyte-mediated neuroinflammation plays an important role in the pathogenesis of chronic pain. Here we investigated the anti-nociceptive effect of systemic treatment with LIG on chronic inflammatory pain and explored possible mechanisms. Unilateral hindpaw injection of complete Freund's adjuvant (CFA) induced persistent pain hypersensitivity. Repeated daily intravenous treatment with LIG, either before or after CFA injection, attenuated CFA-induced thermal hyperalgesia and mechanical allodynia. The same treatment also inhibited CFA-induced keratinocyte-derived chemokine (KC) and monocyte chemoattractant protein-1 (MCP-1) mRNA and protein increases in astrocytes of the spinal cord. In vitro study showed LIG dose-dependently reduced lipopolysaccharide (LPS)-induced upregulation of KC and MCP-1 mRNA in astrocyte cultures. Interestingly, LIG treatment did not affect CFA- or LPS-induced glial fibrillary acidic protein upregulation, but did inhibit CFA-induced phosphorylated nuclear factor-κB (p-NFκB) upregulation in spinal astrocytes. Furthermore, intrathecal injection of NFκB inhibitor attenuated CFA-induced pain hypersensitivity and upregulation of KC and MCP-1 in the spinal cord. Finally, single intravenous injection of LIG attenuated intrathecal injection of LPS-induced mechanical allodynia. The same treatment also decreased LPS-induced NFκB activation and KC and MCP-1 upregulation in the spinal cord. These data indicate that LIG attenuates chronic inflammatory pain potentially via inhibiting NFκB-mediated chemokines production in spinal astrocytes. These results provide direct evidence of the anti-nociceptive and anti-inflammatory effects of LIG, suggesting a new application of LIG for the treatment of chronic inflammatory pain.
© 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  astrocyte; chemokines; chronic pain; complete Freund's adjuvant; neuroinflammation

Mesh:

Substances:

Year:  2014        PMID: 24521480     DOI: 10.1111/ejn.12502

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Ligustilide treatment promotes functional recovery in a rat model of spinal cord injury via preventing ROS production.

Authors:  Weidong Xiao; Aixi Yu; Danli Liu; Jun Shen; Zhigao Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Minocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.

Authors:  Zhen-Peng Song; Bing-Rui Xiong; Xue-Hai Guan; Fei Cao; Anne Manyande; Ya-Qun Zhou; Hua Zheng; Yu-Ke Tian
Journal:  Acta Pharmacol Sin       Date:  2016-05-09       Impact factor: 6.150

3.  Annexin-1 Mimetic Peptide Ac2-26 Suppresses Inflammatory Mediators in LPS-Induced Astrocytes and Ameliorates Pain Hypersensitivity in a Rat Model of Inflammatory Pain.

Authors:  Zhenzhao Luo; Hui Wang; Shiqiang Fang; Li Li; Xing Li; Jing Shi; Man Zhu; Zheqiong Tan; Zhongxin Lu
Journal:  Cell Mol Neurobiol       Date:  2019-11-13       Impact factor: 5.046

4.  Ligustilide Ameliorates Inflammatory Pain and Inhibits TLR4 Upregulation in Spinal Astrocytes Following Complete Freund's Adjuvant Peripheral Injection.

Authors:  Bin Qian; Feng Li; Lin-Xia Zhao; Yu-Lin Dong; Yong-Jing Gao; Zhi-Jun Zhang
Journal:  Cell Mol Neurobiol       Date:  2015-06-27       Impact factor: 5.046

5.  Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization.

Authors:  C Leiguarda; A Villarreal; C Potilinski; T Pelissier; M F Coronel; J Bayo; A J Ramos; A Montaner; M J Villar; L Constandil; Pablo R Brumovsky
Journal:  J Neuroimmune Pharmacol       Date:  2021-01-27       Impact factor: 4.147

6.  Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.

Authors:  Yujie Huang; Yifan Zhang; Ting Wan; Yu Mei; Zihao Wang; Jincheng Xue; Yi Luo; Min Li; Shuhuan Fang; Huafeng Pan; Qi Wang; Jiansong Fang
Journal:  Cell Biol Toxicol       Date:  2020-10-31       Impact factor: 6.691

7.  Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis.

Authors:  Jun-Jie Chen; Lin Dai; Lin-Xia Zhao; Xiang Zhu; Su Cao; Yong-Jing Gao
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

8.  CXCL13/CXCR5 enhances sodium channel Nav1.8 current density via p38 MAP kinase in primary sensory neurons following inflammatory pain.

Authors:  Xiao-Bo Wu; De-Li Cao; Xin Zhang; Bao-Chun Jiang; Lin-Xia Zhao; Bin Qian; Yong-Jing Gao
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

9.  Ligustilide Relieves Complete Freund's Adjuvant-induced Mechanical Hyperalgesia through Inhibiting the Activation of Spinal c-Jun N-terminal Kinase/c-Jun Pathway in Rats.

Authors:  Yi-Rui Wang; Hui Xu; Min Tao; Li-Hua Xu; Xin-Chun Fu
Journal:  Pharmacogn Mag       Date:  2017-11-13       Impact factor: 1.085

10.  Z-ligustilide and anti-inflammatory prostaglandins have common biological properties in macrophages and leukocytes.

Authors:  Joseph Schwager; Lidia Gagno; Nathalie Richard; Werner Simon; Peter Weber; Igor Bendik
Journal:  Nutr Metab (Lond)       Date:  2018-01-16       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.